Hélène Vanacker
Impact in
-
- Uterine Myomas and Treatments
- Endometrial and Cervical Cancer Treatments
-
- Ovarian cancer diagnosis and treatment
Papers in
-
- Sarcoma Diagnosis and Treatment 10
- Advanced Breast Cancer Therapies 3
- Oncology 10
- CAR-T cell therapy research 4
- PARP inhibition in cancer therapy 4
- Co-authors
- Mehdi Brahmi (18 shared papers)Armelle Dufresne (14 shared papers)Isabelle Ray‐Coquard (8 shared papers)Jean‐Yves Blay (13 shared papers)Franck Tirode (10 shared papers)Daniel Pissaloux (8 shared papers)Susana Banerjee (1 shared paper)Jessica Vetters (1 shared paper)
- Journals
- Current Opinion in Oncology (4 papers)ESMO Open (3 papers)Annals of Oncology (2 papers)Cancers (2 papers)Critical Reviews in Oncology/Hematology (1 paper)
- Partner nations
- FranceUnited StatesUnited Kingdom
In The Last Decade
Hélène Vanacker
31 papers receiving 246 citations
Peers
Comparison fields: 5 of 50
- Obstetrics and Gynecology 29
- Reproductive Medicine 29
- Oncology 83
- Pulmonary and Respiratory Medicine 87
- Rheumatology 32
Countries citing papers authored by Hélène Vanacker
This map shows the geographic impact of Hélène Vanacker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hélène Vanacker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hélène Vanacker more than expected).
Fields of papers citing papers by Hélène Vanacker
This network shows the impact of papers produced by Hélène Vanacker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hélène Vanacker. The network helps show where Hélène Vanacker may publish in the future.
Co-authors
The 25 scholars most cited alongside Hélène Vanacker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 32 | |
| 2 | 2017 | 31 | |
| 3 | 2020 | 26 | |
| 4 | 2020 | 19 | |
| 5 | 2020 | 15 | |
| 6 | 2023 | 14 | |
| 7 | 2023 | 13 | |
| 8 | 2020 | 12 | |
| 9 | 2022 | 11 | |
| 10 | 2020 | 8 | |
| 11 | 2020 | 6 | |
| 12 | 2024 | 5 | |
| 13 | 2022 | 5 | |
| 14 | 2017 | 5 | |
| 15 | 2021 | 5 | |
| 16 | 2023 | 4 | |
| 17 | 2023 | 4 | |
| 18 | [Advanced luminal breast cancer (hormone receptor-positive, HER2 negative): New therapeutic options in 2015]. | 2015 | 3 |
| 19 | 2024 | 3 | |
| 20 | 2024 | 3 |
About Hélène Vanacker
Hélène Vanacker is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Immunology, Reproductive Medicine and Molecular Biology, having authored 34 papers that have together received 247 indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (10 papers), Ovarian cancer diagnosis and treatment (5 papers), CAR-T cell therapy research (4 papers), PARP inhibition in cancer therapy (4 papers), Advanced Breast Cancer Therapies (3 papers), Gastrointestinal Tumor Research and Treatment (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers) and Endoplasmic Reticulum Stress and Disease (1 paper). The work is most often cited by research in Obstetrics and Gynecology (29 citations), Reproductive Medicine (29 citations), Oncology (83 citations), Pulmonary and Respiratory Medicine (87 citations) and Rheumatology (32 citations). Hélène Vanacker has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Mehdi Brahmi, Armelle Dufresne, Isabelle Ray‐Coquard, Jean‐Yves Blay, Franck Tirode, Daniel Pissaloux, Susana Banerjee, Jessica Vetters, Philipp Harter and Domenica Lorusso. Their work appears in journals such as Current Opinion in Oncology, ESMO Open, Annals of Oncology, Cancers and Critical Reviews in Oncology/Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.